研究报告 |
|
|
|
|
腺病毒介导的人巨细胞病毒UL49基因小鼠模型的建立 |
杨丹,崔延伟,李弘剑,李月琴,周琪,曾志锋,张欣,杨光,周天鸿** |
暨南大学基因工程药物国家工程研究中心 暨南大学生命科学技术学院 广州 510632 |
|
Recombinant Adenovirus Vector Mediated Expression of HCMV UL49 Gene in Mice |
YANG Dan,CUI Yan-wei,LI Hong-jian,LI Yue-qin,ZHOU Qi,ZENG Zhi-feng,ZHANG Xin,YANG Guang,ZHOU Tian-hong |
National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, Guangzhou 510632, China |
引用本文:
杨丹 崔延伟 李弘剑 李月琴 周琪 曾志锋 张欣 杨光 周天鸿. 腺病毒介导的人巨细胞病毒UL49基因小鼠模型的建立[J]. 中国生物工程杂志, 2010, 30(01): 1-6.
YANG Dan, CUI Yan-Wei, LI Hong-Jian, LI Ru-Qin, ZHOU Qi, CENG Zhi-Feng, ZHANG Xin, YANG Guang, ZHOU Tian-Hong. Recombinant Adenovirus Vector Mediated Expression of HCMV UL49 Gene in Mice. China Biotechnology, 2010, 30(01): 1-6.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/
或
https://manu60.magtech.com.cn/biotech/CN/Y2010/V30/I01/1
|
[1] Walter D,Cassie C,Hong L,et al. Functional profiling of a human cytomegalovirus genome.PNAS,2003,100(24): 1422314228.
[2] Martin S, Hans W D, Jindrich C. Human cytomegalovirus retinitis: pathogenicity, immune evasion and persistence.Trends in Microbiology, 2003,11(4): 171178.
[3] Andrew J D, Aidan D,Parvis A,et al. The human cytomegalovirus genome revisited:comparison with the chimpanzee cytomegalovirus genome. Journal of General Virology,2003,84(1):1728.
[4] Mocarski E S, Courcelle C T. Cytomegaloviruses and their replication. In: Knipe D M, Howley P M. Fields virology. Philadelphia: Lippincott Williams & Wilkins, 2001. 26292674.
[5] Kern E R. Pivotal roles of animal models in the development of new therapies for cytomegalovirus infections .Antiviral Res, 2006, 71(23):164171.
[6] Bidanset D J, Rybak R J, Hartline C B, et al. Replication of human cytomegalovirus in severe combined immunodeficient mice implanted with human retinal tissue. Infect Dis,2001,184(2):192195.
[7] DiLoreto Jr D,Epstein L G, Lazar E S, et al. Cytomegalovirus infection of human retinal tissue:an in vivo model. Lab Invest, 1994,71(1):141148.
[8] Kern E R,Rybak R J,Hartline C B, et al. Predictive efficacy of SCIDhu mouse models for treatment of human cytomegalovirus infections. Antivir Chem Chemother ,2001,12(Suppl 1):149156.
[9] Mocarski E S,Bonyhadi M,Salimi S, et al.Human cytomegalovirus in a SCIDhu mouse: thymic epithelial cells are prominent targets of viral replication. PNAS, 1993, 90(1):104108.
[10] Weber O,Bender W,Eckenberg P, et al. Inhibition of murine cytomegalovirus and human cytomegalovirus by a novel nonnucleosidic compound in vivo. Antiviral Res, 2001,49(3):179189.
[11] Centra M, Ratych R E,Cao G L, et al. Culture of bovine pulmonary artery endothelial cells on Gelfoam blocks. FASEB J, 1992,6(2):31173121.
[12] Zhang W W.Development and application of adenoviral vetors for gene theraphy of cancer. Cancer Gene Ther, 1999,6(2):113138.
[13] Flotte T R,Cater B J. Adenoassociated virus vectors for gene therapy. Gene Ther,1995,2(6):357362.
[14] Ng P, Parks R J, Cummings D T, et al. A high efficiency Cre / loxp based system for construction of adenoviralvectors. Hum Gene Ther, 1999, 10 (16):2667 2672. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|